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Abstract. Improving health worldwide will require rigorous quantifica-
tion of population-level trends in health status. However, global-level
surveys are not available, forcing researchers to rely on fragmentary
country-specific data of varying quality. We present a Bayesian model
that systematically combines disparate data to make country-, region-
and global-level estimates of time trends in important health indicators.
The model allows for time and age nonlinearity, and it borrows
strength in time, age, covariates, and within and across regional coun-
try clusters to make estimates where data are sparse. The Bayesian
approach allows us to account for uncertainty from the various aspects
of missingness as well as sampling and parameter uncertainty. MCMC
sampling allows for inference in a high-dimensional, constrained param-
eter space, while providing posterior draws that allow straightforward
inference on the wide variety of functionals of interest.
Here we use blood pressure as an example health metric. High blood
pressure is the leading risk factor for cardiovascular disease, the leading
cause of death worldwide. The results highlight a risk transition, with
decreasing blood pressure in high-income regions and increasing levels
in many lower-income regions.
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1. INTRODUCTION
Variations and trends in health outcomes and risk
factors across the globe have received greatly in-
creased attention in recent years, in part driven by
the UN’s Millennium Development Goals, the in-
crease in international funding for global health and
the demand for objective evidence about the effec-
tiveness of interventions. There has been a concomi-
tant focus on data sources and quantitative methods
for population-level measures of health status. How-
ever, global-level surveys are not available, forcing
researchers to rely on fragmentary country-specific
data of varying quality.
This is an electronic reprint of the original article
published by the Institute of Mathematical Statistics in
Statistical Science, 2014, Vol. 29, No. 1, 18–25. This
reprint differs from the original in pagination and
typographic detail.
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The Global Burden of Diseases, Injuries and
Risk Factors Study (GBD, www.globalburden.org),
which aims to quantify the relative contributions of
different diseases and injuries, and their risk fac-
tors, to morbidity and mortality worldwide, offers
a demonstration of these challenges. For example,
despite cardiovascular diseases being the leading
causes of death worldwide (Lozano et al., 2013),
our understanding of their trends is almost en-
tirely based on specific cohorts and communities,
primarily in high-income countries. As part of the
GBD Study, we set out to estimate trends in car-
diometabolic risk factors over the past 30 years for
all nations.
In this paper we present a Bayesian model devel-
oped to address these issues by combining disparate
data sources to complete the largest-ever analysis of
metabolic risk factors and the first global analysis of
trends. Our model has been used to analyze global
trends in systolic blood pressure (Danaei et al.,
2011b), serum total cholesterol (Farzadfar et al.,
2011), body mass index (Finucane et al., 2011) and
fasting plasma glucose (Danaei et al., 2011a).
Here, we focus on the blood pressure analysis as an
illustrative example of model development and the
advantages of using the Bayesian paradigm. Kear-
ney et al. (2004, 2005) and Lawes et al. (2004) were
influential in demonstrating the importance of this
risk factor, which is responsible for more than 9 mil-
lion annual deaths, more than any other risk fac-
tor (Lim et al., 2013). These analyses, however, were
based on only a small subset of available data. Fur-
ther, they did not assess trends over time systemat-
ically, did not distinguish nationally-representative
surveys from sub-national and community-based
studies, and did not take into account the miss-
ingness of data from entire countries or age groups
when quantifying uncertainty.
In addition to addressing these deficiencies, our
approach differs in important ways from other recent
modeling of global health. Rajaratnam et al. (2010)
and Hogan et al. (2010), for example, modeled global
adult and maternal mortality, respectively. These
studies used investigator-chosen smoothing param-
eters and implemented a two-stage estimation pro-
cedure, which prevents uncertainty from propagat-
ing through the modeling process. We, on the other
hand, estimate all parameters as part of a single
model, allowing all sources of uncertainty to be re-
flected in our inference. Furthermore, whereas they
decided a priori how much weight to give high-
vs. low-quality studies, our model estimates these
weights empirically based on the noisiness observed
in the different types of data sources.
2. THE DATA
For 199 countries and territories, from 1980 to
2008, we estimate trends in mean systolic blood
pressure (SBP) for adults 25 years of age and older.
We accessed numerous unpublished studies and re-
viewed published studies to collate comprehensive
data on SBP. We grouped the 199 analysis coun-
tries into 21 subregions using the classifications of
the GBD Study. We grouped the subregions into
seven merged regions. Details are given in Danaei
et al. (2011b).
The primary challenge of this analysis is the frag-
mented nature and varying quality of the data, avail-
able only from some countries, in some years and
for some age groups. For roughly one-third of all
countries, no data exist at all. Furthermore, many
studies cover only rural or only urban populations.
Although a portion of the data comes from national
surveys with sample weights, most data come from
epidemiologic studies not intended to be nationally
representative. In addition, many data sources suffer
from small sample sizes.
3. WHY BAYES?
Given these patterns of data sparsity and missing-
ness, a hierarchical model is needed to provide infer-
ence for all country–year–age triplets and to account
for missingness when aggregating to the regional and
global levels. The hierarchy provides prior distribu-
tions that enable us to borrow strength over time,
countries and age, while enforcing plausible param-
eter constraints.
In principle, a non-Bayesian hierarchical mixed
model is an alternative, fit by maximum marginal
likelihood after integrating over all the random ef-
fects, but the predictive uncertainty would not have
included the substantial uncertainty from hyperpa-
rameter estimation. Furthermore, with 23 hyperpa-
rameters, this would have been a challenging opti-
mization in practice, especially given the parameter
constraints. In addition, it would have been difficult
to interpret the hierarchical model in a non-Bayesian
fashion, with mean blood pressure for a country as a
random effect, given that the fixed countries of the
world are not drawn from some large population of
possible countries.
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MCMC sampling has the added advantage of pro-
viding Bayesian imputations of risk factor levels at
any level of aggregation (over age groups, times,
countries, etc.) as a product that the many stake-
holders in this work can use to do their own analy-
ses that easily incorporate uncertainty; our analysis
includes functionals such as the linear component
of blood pressure time trends and the population-
weighted, age-standardized global mean blood pres-
sure level (see Section 6).
4. THE MODEL
Our basic strategy is to fit a Bayesian hierarchi-
cal model that clusters countries within geographi-
cal subregions and regions of the globe, thereby bor-
rowing strength from countries with data. Our ap-
proach treats countries as exchangeable in the ab-
sence of other information, after accounting for co-
variates. To the basic model we add smooth time
trends and age effects as well as country- and study-
level covariates. We specify a heteroscedastic, multi-
component error structure to account for the fact
that not all studies are nationally representative.
Models for women and men are fit separately.
Throughout, bold characters denote vectors and
matrices. For each age group h from study i, the
model inputs a sample average and a sample stan-
dard deviation of SBP values (yh,i and sh,i) as well
as a sample size (nh,i). We let ti denote the year
in which study i was conducted and we use square
brackets to denote group membership such that j[i]
is the country j in which study i was conducted.
The likelihood is
yh,i|aj[i], bj[i], uj[i],ti,β, γi, ei, τ
2
i
∼N
(
aj[i]+ bj[i]ti + uj[i],ti(4.1)
+X′iβ+ γi(zh) + ei,
s2h,i
nh,i
+ τ2i
)
.
aj and bj denote the country-specific intercept and
linear time slope for the jth country (j = 1, . . . , J =
199). These intercepts and slopes are modeled hier-
archically, as discussed in Section 4.1. uj , a vector
of length T = 29, models smooth nonlinear change
over discretized time (t= 1980, . . . ,2008) in country
j (Section 4.2). The matrix X contains study- and
country-level covariates (Section 4.3). The zh’s are
age-group values and the γi(·)’s are their smoothly-
varying study-specific effects; we describe the flexi-
ble age model in Section 4.4. Finally we add a ran-
dom effect, ei, to capture study-level heterogeneity,
allowing us to combine data from disparate sources,
as described in Section 4.5.
The likelihood variance has two terms. s2h,i/nh,i
represents the known sampling uncertainty of mean
SBP for a given age group within a study. We model
additional residual variability across age groups
within a study as τ2i (Section 4.5).
4.1 Linear Components of the Time Trends
We model the intercepts and slopes in a hierarchi-
cal fashion, with each country-specific intercept, aj ,
and slope, bj , composed of country- (c), subregion-
(s), region- (r) and global-level (g) components. Let-
ting k index subregions and l index regions, we have
aj = a
c
j + a
s
k[j]+ a
r
l[j]+ a
g,
bj = b
c
j + b
s
k[j]+ b
r
l[j]+ b
g.
The constituent random intercepts (ac, as and ar)
and slopes (bc, bs and br) each have a normal prior
with mean zero and variance equal to κca, κ
s
a, κ
r
a, κ
c
b,
κsb or κ
r
b , respectively. The variance parameters de-
termine the degree of intercept (κa) and slope (κb)
shrinkage performed at the country- (κc), subregion-
(κs) and region-levels (κr). For the variance param-
eters, we use a flat prior on the standard deviation
scale (Gelman, 2006). We use flat priors for ag and
bg as well. All flat priors were truncated at 0 and
1000.
4.2 Nonlinear Change in Time
We also model smooth nonlinear change over time
in country j hierarchically: uj = u
c
j + u
s
k[j] + u
r
l[j] +
u
g, with each component of the nonlinear trend
modeled using a discrete second-order Gaussian au-
toregressive prior (Rue and Held, 2005). In particu-
lar, we model each of the vectors ucj (j = 1, . . . , J),
u
s
k (k = 1, . . . ,K), u
r
l (l = 1, . . . ,L) and u
g using
a normal prior with mean zero and precision λcP,
λsP, λrP and λgP, respectively. The fixed matrix
P penalizes second differences.
In this portion of the model, we enforce two con-
straints to achieve identifiability. We give the pre-
cision parameters a flat prior on the standard de-
viation scale (Gelman, 2006), truncating logλ≤ 15,
as larger values correspond to essentially no extra-
linear temporal variability. We also enforce orthogo-
nality between the linear and nonlinear components
of the time trends by constraining the mean and
slope of each uc, us, ur and ug to be zero.
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4.3 Covariate Effects
We include six time-varying, country-level covari-
ates: national income, national urbanization and
four measures of national food availability (namely,
the first four terms from a principal components
analysis summarizing the availability of many food
types, e.g., meats, pulses, spices). We include inter-
actions of income and urbanization with time be-
cause the associations may have changed over time
(e.g., as treatment for high blood pressure became
available). We smoothed the country-level covariates
using a triangularly-weighted moving average with
weights decreasing from the year of data collection
to the ninth year prior.
At the study level, we include two covariates
to account for potential bias from data sources
that are not representative of national populations.
We account for potentially time-varying effects of
sources that are not nationally representative. In
addition, we account for differences between study-
and country-level urbanization using an interaction
term.
4.4 Age Model
Mean SBP generally varies as a nonlinear function
of age (Singh et al., 2012). We model the age effect
using cubic splines with fixed knots at 45 and 60
years:
γi(zh) = γ1izh + γ2iz
2
h + γ3iz
3
h
+ γ4i(zh − 45)
3
+ + γ5i(zh − 60)
3
+.
We centered the age variable (zh) at 50 years of age
to reduce dependence among model parameters. The
γ’s are modeled as γsi = ψs + φsµi + csj[i] for s =
1, . . . ,5, where µi = aj[i] + bj[i]t+X
′
iβ + uj[i],ti + ei
is the blood pressure level for the 50-year-old age
group. We model the spline coefficients for study
i as a linear effect of the level for this baseline
group because blood pressure tends to increase more
sharply as a function of age in countries with higher
SBP levels (Singh et al., 2012). To this, we add a
country-specific random effect to account for addi-
tional country-specific variation in the age effect,
with csj |σ
2
s ∼ N (0, σ
2
s) and flat priors for the σs’s
(Gelman, 2006).
The age model above is continuous in age. How-
ever, the blood pressure means are reported for dis-
crete age groups (e.g., mean SBP for 35–44-year-
olds). As a simplification, we used the midpoint of
each age range (e.g., 40 years) as the age value for
each data point.
4.5 Study-Specific Random Effects and Residual
Age-by-Study Variability
We account for study-level effects (above and be-
yond sampling variability) that are consistent across
age groups by including a study-specific random ef-
fect, ei. We model these random effects as being
normally distributed with a variance that depends
on how representative the study is of the country’s
population:
Var(ei) =


νw, if study i is nationally
representative with sample weights,
νu, if study i is nationally
representative without sample
weights,
νs, if study i is “sub-national” (i.e.,
covers multiple provinces/states),
νc, if study i is from
an individual community.
Exploratory analysis and subject-matter knowledge
suggest that even weighted national studies may
have more variability than can be accounted for by
sampling variability because of issues with study de-
sign and quality; this is accounted for through the
νw variance term. We then assume that studies that
are increasingly less representative have increasing
random effects variances, imposing the set of con-
straints νw < νu < νs < νc. The assumption that
we should smooth over (rather than fitting) aber-
rant data points is substantiated by the larger-than-
expected variability among studies from country-
years in which we have multiple nationally repre-
sentative studies with sample weights.
We also include a variance term for within-study
errors (above and beyond sampling variability) that
differ between age groups. As with the study-specific
random effects, we use variance parameters that dif-
fer depending on the representativeness of the study,
where τ2w, τ
2
u , τ
2
s and τ
2
c are defined in an analogous
fashion to νw, νw, νs and νs and with an analogous
ordering constraint.
5. COMPUTATION
We fit the model via Markov chain Monte Carlo
(MCMC), using a combination of conjugate sam-
pling steps and Metropolis–Hastings updates, with
details provided in Danaei et al. (2011b). We note
that in hierarchical models there can be strong de-
pendence between parameters across levels of the
model, in particular, dependence of random effects
TRENDS IN MEASURE OF HEALTH STATUS 5
and their associated variance components. To ad-
dress this, we jointly sampled random effects with
their hyperparameters (Rue and Held, 2005, Section
4.1.2), which greatly improved convergence and mix-
ing. Finally, we note that while it is possible to ana-
lytically integrate out those parameters in the mean
of the normal likelihood whose priors were also nor-
mal, we avoided doing so because it would result in
off-diagonal structure in the covariance of the likeli-
hood, requiring large matrix manipulations in order
to calculate the marginal likelihood.
6. MODEL CHECKING AND INFERENCE
We used posterior predictive checks to ensure that
we had not omitted important interactions and used
cross-validation to ensure that we had not overfit our
data. In addition, we assessed the sensitivity of our
inference to the inclusion of country-level covariates.
All model checks were reassuring and full results are
given in Danaei et al. (2011b). In particular, in the
cross-validation our model predicted the known-but-
masked data very well: the 95% prediction intervals
covered 94% of excluded study mean values for both
men and women, consistent with the expected 95%.
We draw from the posterior predictive distribu-
tion for the mean SBP in each country, age and
year with covariates corresponding to a weighted na-
tional study that represents both urban and rural
populations. We then estimate year- and age-group-
specific mean SBP at the subregion level using a
population-weighted average of the mean SBP val-
ues for the countries within the subregion, with anal-
ogous estimates for the regions and globe. We also
estimate mean SBP marginalizing over age by cal-
culating age-standardized values, with weights for
each age group from the World Health Organiza-
tion standard population. Epidemiologists are in-
terested in the linear component of the SBP time
trends to assess whether health status has generally
been improving. To linearize, at each iteration we fit
a simple linear regression of the country’s mean SBP
values against year, collecting the resulting slopes
across MCMC iterations.
7. RESULTS
We additively decomposed the variability in the
country–year predictions for 50-year-olds to under-
stand the variation attributable to mean and time
trends at each of the levels of the hierarchy. For
each country and MCMC iteration, we decomposed
the predicted time series into mean, linear trend
and nonlinear trend (residual). We then decom-
posed each of these terms into country-specific vari-
ation, subregional variation, regional variation and
global variation, treating country–time points as the
units—that is, the subregional, regional and global
terms were averages of the countries within each
subregion, region and globe. This weighting gives
greater emphasis to subregions with more countries
than would treating subregions as units within re-
gions and regions as units within the globe. As can
be seen in Table 1, country and region variation pre-
dominate, and cross-country variation is more im-
portant than temporal variation.
For females, we note that vc (the variance of
random effects specific to community studies) is
Table 1
Decomposition of variability in predictions (%), with 95% credible intervals
subscripted
Country Subregion Region Globe Total
Female
Mean 26.538.651.8 3.47.614.2 16.926.938.5 60.373.184.4
Lin. trend 2.06.815.0 0.72.76.9 3.68.515.2 0.02.610.1 11.520.631.5
Nonlin. trend 0.84.09.3 0.11.02.8 0.11.03.2 0.00.31.4 1.56.313.8
Total 37.449.461.0 6.211.319.8 25.236.448.5 0.12.910.7
Male
Mean 26.440.154.1 5.710.317.1 15.226.037.3 63.076.587.3
Lin. trend 0.93.58.7 0.32.36.9 1.14.08.2 0.01.57.2 5.111.319.9
Nonlin. trend 1.96.613.7 0.41.84.4 0.42.04.9 0.12.06.4 4.312.323.2
Total 37.350.263.5 8.414.422.9 20.732.043.9 0.33.511.0
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Fig. 1. Raw data with model fits for 50-year-old females. The solid line represents the posterior mean, the shaded area the
pointwise 95% credible interval. The vertical error bars show the 95% intervals due to sampling variability (±2s/√n).
large (33.0, 27.9–38.8), suggesting that studies of
individual communities do not reflect the country’s
mean SBP level accurately. Although vw (the anal-
ogous variance for nationally representative studies
with sample weights) is smaller (10.8, 6.5–16.0), its
magnitude is nonnegligible. Consistent with this, if
we include study-specific variation for weighted na-
tional studies in the variance decomposition above,
this accounts for 22.8% (13.6–34.4%) of the varia-
tion for females. This indicates that even weighted
national studies, the highest quality studies in this
analysis, may have imperfect study design and
quality, reflected in the anomalous 2004 study in
the U.S. (Figure 1). Similar conclusions hold for
males.
Figure 1 shows example model fits for 50-year-
old females from three countries with differing data
density and study representativeness.
Comparing across subregions in 2008, female SBP
was highest in some east and west African countries,
with means of 135 mmHg or greater. Male SBP was
highest in Baltic and east and west African coun-
tries, where mean SBP reached 138 mmHg or more.
Men and women in western Europe had the highest
SBP among high-income regions.
Figure 2 shows age-standardized regional and
global trends, highlighting a global transition in
which cardiovascular disease risk factor levels have
increased in lower-income regions to become com-
parable to—and in places even surpass—those in
high-income regions, in which levels have decreased.
A costly epidemic of high blood pressure in low-
income countries may be the most salient feature of
the global cardiovascular risk transition in the com-
ing decades.
8. DISCUSSION
The results of our analyses using this modeling
strategy were published in a series of four risk-
factor-specific papers in 2011 in The Lancet that re-
ceived press coverage at the national and global level
(including the Washington Post, International Her-
ald Tribune, Guardian, Times of India and BBC ).
The results were used in theWHO Global Status Re-
port on noncommunicable diseases (NCDs; WHO,
2011) and The World Health Statistics, and were
presented at the First Global Ministerial Conference
on Healthy Lifestyles and NCD Control. They were
used to select ambitious but achievable targets for
cardiovascular disease risk factors for the UN high-
level meeting on NCDs, a task that requires a thor-
ough understanding of past trends. In addition, our
results were used by the US National Academy of
Sciences Panel on International Health Differences
in High Income Countries (Woolf and Aron, 2013)
to understand the role of risk factors for cardiovas-
cular disease in cross-population health differentials.
Our results were also used to calculate the global
burden of disease attributable to CVD risk factors
(Lim et al., 2013), a calculation which requires com-
parable estimates by age, sex, year and country. Re-
searchers working on non-CVD conditions have also
used our results on CVD risk factors, for example,
to examine the role of obesity on cancers and of
maternal obesity on stillbirths in different countries
(Flenady et al., 2011). Finally, our close collabora-
tion with leading global health researchers is helping
to place Bayesian methods that rigorously synthe-
size fragmentary data at the heart of the conversa-
tion about methods for measures of health status.
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Fig. 2. Male (blue) and female (orange) trends (estimated separately) by region. The solid line represents the posterior mean
and the shaded area the pointwise 95% credible interval. Numerical values are the estimated linearized time trends.
While our confidence in the model is bolstered by
the cross-validation results that indicate that our
inference reflects the important sources of variabil-
ity, there are a number of potential model improve-
ments. These include further consideration of ad-
ditional covariates, nonlinear covariate effects and
covariate interactions, including covariate effects
that vary by region. In addition, we would like to
have considered more flexible models for the effects
of nonnationally representative studies and stud-
ies representing only rural or urban populations.
While data sparsity led us to assume that a num-
ber of model parameters were constant across re-
gion, it would be worthwhile to investigate allowing
the country-level variance components, including
the autoregressive smoothing parameters, to vary
by region. Finally, our model assessment indicated
room for improvement in the fitted age effect in some
countries; in particular, age effects may vary with
time beyond our modeled interaction with the over-
all time-varying level of mean SBP.
Beyond such model selection issues, we close by
noting two important open issues. First, cross-vali-
dation can only assess our quantification of predic-
tive uncertainty in relation to the observed data; the
presence of additional variability (beyond sampling
variability) related to shortcomings in study qual-
ity in the weighted nationally representative studies
makes it difficult to assess our quantification of un-
certainty in the true country-level trends. Second,
we assume that the presence/absence of data is non-
informative; if the studies or countries represented
in the data set are not missing at random, our re-
sults would be biased, with trend estimates affected
by data collection patterns. For example, if countries
with more airports tend to attract both researchers
and fast food franchises, then we could be at risk for
overestimating SBP levels.
In summary, efforts to improve global health
will depend on reliable estimates of health sta-
tus, and many of these estimates will be based
on fragmentary data from disparate sources. The
Bayesian paradigm provides a framework for rigor-
ously combining these data sources to obtain coher-
ent country-, region- and global-level inference.
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